Collaborating through Complexity: A Case Study in Global, Pan-Tumor CDx Development
- Explore insights from Eli Lilly & Company and Foundation Medicine’s partnership to develop a pan-tumor companion diagnostic for Retevmo
- Discover the power of expertise, collaboration, and creative validation strategies for overcoming complexities such as sample limitations and diverse global regulatory requirements
- Learn how the right partnership can accelerate patient access to therapy